Applying Population Management Best Practices to Preventative Genomic Medicine Trial

Part of paid clinical trials in Denver, Colorado.

Sponsor
University of Washington
Study ID
NCT07053813
Status
Enrolling By Invitation

Conditions

  • Neoplastic Syndromes, Hereditary

Eligibility Criteria

Sex
ALL
Age
18 Years - 75 Years
Healthy Volunteers
Not accepted

Interventions

  • Web resources — BEHAVIORAL
    Mailed educational resources through portal and USPS mail
  • Personalized outreach — BEHAVIORAL
    Phone call to discuss due and overdue screening and other personalized risk management recommendations

Study Details

Preventive genomic medicine, particularly identification of individuals with inherited cancer risk, can improve longevity and quality of life, yet adherence to risk management following cancer genomic testing is poor. The proposed research refines and evaluates two highly scalable population management interventions, web resources and personalized outreach, designed to improve access and use of recommended risk management following cancer genetic testing. Research activities will be conducted in a vertically integrated health system and federally qualified health center and will address post-testing quality and patient safety concerns that are minimizing patient benefit and slowing investments in real world genomic medicine implementation.

Key Dates

Start date
Jul 1, 2025
Status verified
Jun 2025
Primary completion
Jul 1, 2027
Completion
Jul 1, 2028

Study Design

Enrollment
900 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION

Arms

  • No Intervention: Usual care
    No intervention
  • Experimental: Web resources
    Individuals randomized to web resources will be sent materials refined in Aim 1 (via patient portal and USPS mail) within 1-2 weeks after their birthday. Messages will be sent in English or preferred language noted in the EHR.
  • Experimental: Personalized outreach
    Individuals randomized to personalized outreach will be contacted by the care coordinator in their birthday month for a brief phone call discussing due and overdue screening. The coordinator will attempt to contact patients up to 3 times to complete the phone conversation before considering them opting out of the intervention. If needed, the coordinator can place orders and pending referrals for PCP signature.

Primary Outcome Measure

Proportion time covered [ Time Frame: 12 months following randomization ]

Locations (2)

FacilityCityStateZIPSite coordinators
Denver HealthDenverColorado80204-
Kaiser NorthwestPortlandOregon97227-

Find similar trials in Denver, CO